Raras
Buscar doenças, sintomas, genes...
Síndrome Ehlers-Danlos hipermobilidade
ORPHA:285CID-10 · Q79.6CID-11 · LD28.1YOMIM 130020DOENÇA RARA

A síndrome de Ehlers-Danlos, tipo hipermobilidade (HT-EDS) é a forma mais frequente de SDE, um grupo de doenças hereditárias do tecido conjuntivo, e é caracterizada por hiperfrouxidão articular, hiperextensibilidade leve da pele, fragilidade tecidual e manifestações extramusculoesqueléticas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Ehlers-Danlos, tipo hipermobilidade (HT-EDS) é a forma mais frequente de SDE, um grupo de doenças hereditárias do tecido conjuntivo, e é caracterizada por hiperfrouxidão articular, hiperextensibilidade leve da pele, fragilidade tecidual e manifestações extramusculoesqueléticas.

Pesquisas ativas
6 ensaios
28 total registrados no ClinicalTrials.gov
Publicações científicas
385 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
12.5
Europe
Início
All ages
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, SC, RS, ES +10CID-10: Q79.6
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
10 sintomas
🦴
Ossos e articulações
9 sintomas
🧬
Pele e cabelo
6 sintomas
💪
Músculos
4 sintomas
❤️
Coração
4 sintomas
🧠
Neurológico
3 sintomas

+ 31 sintomas em outras categorias

Características mais comuns

100%prev.
Hipermobilidade articular
Muito frequente (99-80%)
90%prev.
Anormalidade do sono
Muito frequente (99-80%)
90%prev.
Acrocianose
Muito frequente (99-80%)
90%prev.
Morfologia anormal do pé
Muito frequente (99-80%)
90%prev.
Luxação do quadril
Muito frequente (99-80%)
90%prev.
Artralgia
Muito frequente (99-80%)
75sintomas
Muito frequente (13)
Frequente (21)
Ocasional (38)
Muito raro (2)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 75 características clínicas mais associadas, ordenadas por frequência.

Hipermobilidade articularJoint hypermobility
Muito frequente (99-80%)100%
Anormalidade do sonoSleep abnormality
Muito frequente (99-80%)90%
AcrocianoseAcrocyanosis
Muito frequente (99-80%)90%
Morfologia anormal do péAbnormal foot morphology
Muito frequente (99-80%)90%
Luxação do quadrilHip dislocation
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico385PubMed
Últimos 10 anos200publicações
Pico202577 papers
Linha do tempo
2026Hoje · 2026🧪 2013Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico19
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Ehlers-Danlos hipermobilidade

Centros de Referência SUS

24 centros habilitados pelo SUS para Síndrome Ehlers-Danlos hipermobilidade

Centros para Síndrome Ehlers-Danlos hipermobilidade

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

28 ensaios clínicos encontrados, 6 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
381 papers (10 anos)
#1

Children and adolescents with disorders of gut-brain interaction with comorbid hypermobility and orthostatic intolerance have worse outcomes.

Journal of pediatric gastroenterology and nutrition2026 Mar 19

Disorders of gut-brain interaction (DGBI) affect about 40% of children and are often comorbid with hypermobility spectrum disorders (HSDs) and orthostatic intolerance (OI). However, how these comorbidities impact outcomes in pediatric DGBI is not well understood. This study aimed to compare outcomes in DGBI patients with HSD, OI, both, or neither. We reviewed records of patients aged 9-21 years from a multidisciplinary DGBI clinic. Patients met Rome IV criteria for DGBI and had documented HSD and/or OI diagnoses from specialists in gastroenterology, rheumatology, genetics, cardiology, adolescent medicine, and others. HSD terms included Ehlers-Danlos syndrome, hypermobile Ehlers-Danlos syndrome, and generalized hypermobility; OI terms included postural orthostatic tachycardia syndrome, dysautonomia, and orthostatic hypotension. Clinical data included the following validated questionnaires: abdominal pain index, nausea severity scale, functional disability inventory, patient health questionnaire-9 (Depression), children somatization inventory, pediatric insomnia severity index, pain catastrophizing scale for children, and screen for child anxiety related disorders (Anxiety). We compared DGBI patients with both HSD and OI, those with either disorder, and those without. Of 175 patients, 46% had HSD and 43% had OI. Patients with both HSD and OI had significantly worse nausea, depression, disability, and somatization scores than others (p < 0.01). HSD and OI groups individually also showed worse outcomes than non-HSD/non-OI groups. Moderate correlations were found between depression and anxiety in OI and nausea and disability in HSD. Comorbid HSD and OI worsen DGBI symptoms. Accurate diagnosis and treatment are critical to improving outcomes due to shared autonomic dysfunction.

#2

Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.

Neurology international2026 Feb 11

Background/Objective: It remains unknown whether patients with the more common forms of hypermobility carry an elevated risk for the development of intracranial/cervical artery abnormalities. The objective of this study was to determine the prevalence of unruptured intracranial aneurysms, spontaneous cervical artery dissections, and fibromuscular dysplasia in patients with hypermobile Ehlers-Danlos Syndrome (hEDS) and hypermobility spectrum disorders (HSD) who presented to an academic headache clinic. Methods: This is a retrospective cohort study. We used an electronic medical record to look for all patients seen at the Mayo Clinic Florida Headache Center and EDS Clinic between 2019 and 2025 with a diagnosis of hEDS or HSD and neuroimaging of both the intracranial and cervical arteries. Results: There were 103 patients who met the inclusion criteria. There was no statistically significant difference between hEDS and HSD patients in developing cerebral/cervical arterial anomalies. Of the sample, 95% of the hypermobile patients with abnormal neuroimaging also had migraine. A total of eleven (10.7%) patients (hEDS + HSD) were diagnosed with unruptured intracranial aneurysms. Trends included age less than 50 years, small aneurysms in the anterior circulation, and having migraine with aura. Five (4.8%) patients were diagnosed with spontaneous cervical artery dissection with trends for HSD, over the age of 50 years, vertebral artery involvement and a history of migraine without aura. Six (5.8%) patients were diagnosed with fibromuscular dysplasia with trends for HSD, over the age of 50 years, carotid artery involvement and a history of migraine with aura. Conclusions: This is the first study to identify that patients with the more common type of EDS, HSD and hEDS, and a possible concomitant history of migraine have a heightened risk for the development of unruptured intracranial aneurysms, spontaneous cervical artery dissections, and fibromuscular dysplasia. Our findings suggest the need for targeted screening with intracranial and extracranial arterial imaging for this unique patient population.

#3

Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

PloS one2026

Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are relatively common and disabling multisystem disorders that share overlapping features, including post-infectious onset and similar clinical manifestations such as brain fog, fatigue, muscle pain, and dysautonomia with orthostatic intolerance. These similarities suggest that Long COVID and ME/CFS may share common pathophysiological mechanisms, though the underlying mechanisms remain poorly understood, partly due to the difficulty in quantifying many of the symptoms. This retrospective study evaluated Long COVID and pre-COVID ME/CFS patients who completed autonomic testing between 2018 and 2023 at the Brigham and Women's Faulkner Hospital Autonomic Laboratory. The evaluations included autonomic tests (Valsalva maneuver, deep breathing, tilt-table test, and sudomotor function) with capnography and transcranial Doppler monitoring of cerebral blood flow velocity (CBFv) in the middle cerebral artery, neuropathic assessment through skin biopsies for small fiber neuropathy (SFN), invasive cardiopulmonary exercise testing (ICPET), and laboratory analyses covering metabolic, inflammatory, autoimmune, and hormonal profiles. A total of 143 Long COVID and 170 ME/CFS patients were analyzed and compared to 73 healthy controls and 290 patients with hypermobile Ehlers-Danlos syndrome (hEDS). Tests revealed extensive similarities between Long COVID and ME/CFS, including reduced orthostatic CBFv (92%/88% in Long COVID/ME/CFS), mild-to-moderate widespread autonomic failure (95%/89%), presence of SFN (67%/53%), postural tachycardia syndrome (POTS) (22%/19%), neurogenic orthostatic hypotension (15%/15%) and preload failure (96%/92%, assessed in 25/66 Long COVID/ME/CFS). Patients with hEDS exhibited more severe peripheral neurodegeneration compared to the other groups. Laboratory tests did not distinguish between the conditions. Both Long COVID and ME/CFS demonstrate dysregulation in cerebrovascular blood flow, autonomic reflexes, and small fiber neuropathy, suggesting that these conditions may share a common underlying pathophysiology. However, differing distributions of findings in patients with hEDS raise the question of whether these conditions represent distinct but overlapping syndromes or reflect a shared underlying pathway. Further research is required to clarify the relationship between these conditions and the potential underlying pathophysiological mechanisms.

#4

Sleep-Related Hypoventilation in a Patient With Ehlers-Danlos Syndrome.

Cureus2026 Feb

Although sleep apnea is frequently observed in patients with hypermobile Ehlers-Danlos syndrome (EDS), hypoventilation is uncommon. We present a case of a patient with hypermobile EDS without sleep apnea who was found to have isolated sleep-related hypoventilation. Hypoventilation is defined by elevated PaCO2. It is exacerbated during sleep when ventilatory control sensitivity is diminished. Hypoventilation is further worsened during rapid eye movement (REM) sleep when accessory respiratory muscles are atonic, and breathing is driven solely by the diaphragm. This report highlights the importance of considering hypoventilation in patients with EDS, especially those with relevant risk factors.

#5

A laboratory micro-CT technique is useful to visualize and characterize dermal skin components in a 3D manner.

Experimental and therapeutic medicine2026 May

Bowel and skin biopsies from patients with gastrointestinal disorders have revealed neuropathic changes and altered connective tissue. Patients with postural orthostatic tachycardia syndrome (POTS) often suffer from gastrointestinal symptoms and concomitant hypermobility spectrum disorders, such as hypermobile Ehlers-Danlos syndrome (hEDS). Since the skin is more accessible than the bowel, the aim of the present study was to evaluate skin biopsies in a 3D manner using micro-CT in patients with POTS and controls and relate the findings to symptoms presented. Healthy controls (n=13) and patients with POTS with (n=11) or without hEDS/EDS (n=26) were evaluated. Skin biopsies were taken proximally to the lateral malleolus using a 3 mm needle, fixed in formaldehyde and embedded in paraffin. The samples were harvested using a 1.5 mm punch (length, 2-5 mm) and scanned using a laboratory X-ray phase-contrast micro-CT. Scans were evaluated in a blinded manner and the regularity, thickness and tightness of collagen fiber bundles were assessed. All dermal structures were visible without staining. Intraepidermal nerves were not visible and a number of cell types could not be separated. The percentage of disorganized collagen bundles differed between groups, due to the majority being disorganized in hEDS/EDS (P=0.030). The proportion of any disorganized and parallel bundles throughout the biopsy differed within both patient groups (P<0.001) but not within the control group (P=0.175). There were no differences in symptoms between participants with disorganized bundles and participants without disorganized bundles. In conclusion, X-ray phase-contrast micro-CT was suitable to visualize and characterize dermal skin components in 3D. Patients with POTS and hEDS/EDS exhibited more disorganized collagen bundles; however, the technique cannot currently be used for diagnostic purposes until more patients are examined.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC251 artigos no totalmostrando 200

2026

Sleep-Related Hypoventilation in a Patient With Ehlers-Danlos Syndrome.

Cureus
2026

A laboratory micro-CT technique is useful to visualize and characterize dermal skin components in a 3D manner.

Experimental and therapeutic medicine
2026

Children and adolescents with disorders of gut-brain interaction with comorbid hypermobility and orthostatic intolerance have worse outcomes.

Journal of pediatric gastroenterology and nutrition
2026

Impaired attention and cognitive deficits associated with pain and autonomic symptoms in hypermobile Ehlers-Danlos syndrome: a pilot study.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society
2026

Efficacy of Lidocaine Infusion in the Management of Chronic Myofascial Pain and Intractable Migrainous Headache in a Patient With Hypermobile Ehlers-Danlos Syndrome: A Case Report.

Cureus
2026

Proximity extension assay-based serum proteomic profiling identifies shared protein signatures in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

Clinical proteomics
2026

In-Vivo Force-Length Relationship of the Medial Gastrocnemius Muscle in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

Journal of musculoskeletal &amp; neuronal interactions
2026

Multi-System Genetic Architecture of Hypermobile Ehlers-Danlos Syndrome: Integrating Machine Learning with Subject-Level Genomic Analysis.

Genes
2026

Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.

Neurology international
2026

An Online Pilates Program for People with Hypermobility: A Pragmatic Clinical Trial Looking at Function, Interoception, Kinesiophobia, and Physical Activity Levels.

Journal of multidisciplinary healthcare
2026

Health experiences and outcomes of autistic and non-autistic adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.

BMC medicine
2026

Sex differences in self-reported symptoms and comorbidities associated with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A retrospective study.

Research square
2026

Safety and Impacts of Physical Activity for Individuals Living With Hypermobility Spectrum Disorders and Hypermobile Ehlers-Danlos Syndrome: Protocol for a Scoping Review.

JMIR research protocols
2026

The role of perceived social support for outcomes for the long-term health condition hypermobile Ehlers-Danlos syndrome.

Journal of health psychology
2026

Intercostal nerve radiofrequency ablation for slipping rib syndrome: a case report.

Pain management
2025

Reasons for Participating in the EDS-HEART Program: Holistic and Performative Within a Supportive Community.

International journal of environmental research and public health
2026

Health-Related Quality of Life in Midlife and Older Women With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

Nursing for women's health
2026

Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

PloS one
2026

Association between Ehlers-Danlos syndrome and mast cell activation syndrome: Is there scientific evidence?

Revista clinica espanola
2026

Joint hypermobility syndrome for the urogynaecologist - A narrative review.

European journal of obstetrics, gynecology, and reproductive biology
2026

Outcomes and experiences of patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders undergoing surgical interventions: a scoping review.

Rheumatology international
2026

Nutrient intake, dietary patterns and relationship to symptoms and comorbidities in hypermobile Ehlers-Danlos syndrome.

Clinical nutrition (Edinburgh, Scotland)
2025

A Caregiver's Perspective: Identifying "Zebras"-Listening to Patients is a Clinical Necessity.

Journal of patient experience
2025

Perceived quality of life, fatigue and the metabolic cost of walking in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.

Frontiers in rehabilitation sciences
2026

Distressing Bleeding Symptoms in Interviews of Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder.

Haemophilia : the official journal of the World Federation of Hemophilia
2025

Compression garments in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study.

BMC musculoskeletal disorders
2025

Understanding Comorbidities in Hypermobile Ehlers-Danlos Syndrome: Could a Viral Infection Lead to a Diagnosis?

medRxiv : the preprint server for health sciences
2026

To what extent do the muscles and tendons influence metabolic cost and exercise tolerance in the hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders?

Clinical biomechanics (Bristol, Avon)
2025

Comparative assessment of left common iliac vein compression in patients with hypermobile Ehlers-Danlos syndrome, hypermobility spectrum disorder and healthy controls - A retrospective single-centre study.

Phlebology
2025

Hypothesis paper: high prevalence of Tinel sign in hypermobile Ehlers-Danlos syndrome.

Frontiers in neurology
2025

Treatment Modalities, Pain Response, and Referrals for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Retrospective Study.

Mayo Clinic proceedings. Innovations, quality &amp; outcomes
2025

Connective tissue changes in Ehlers-Danlos syndromes with and without axial spondyloarthropathy.

Journal of ultrasound
2025

Joint Hypermobility: An Under-Recognised Cause of Palpitations, Dizziness, and Syncope in Young Females.

Journal of clinical medicine
2025

Hypermobile Ehlers-Danlos Syndrome With Prominent Gastrointestinal and Autonomic Involvement in a Latin American Patient: A Case Report.

Cureus
2025

Autonomic symptom burden, comorbidities and quality of life in women with Hypermobility Spectrum Disorders and hypermobile Ehlers-Danlos syndrome.

Autonomic neuroscience : basic &amp; clinical
2025

Outcomes of revisional bariatric surgery in patient with hypermobile Ehlers-Danlos syndrome.

Journal of surgical case reports
2025

Exploring the Association Between Median Arcuate Ligament Syndrome and Hypermobile Ehlers-Danlos Syndrome: A Case Report.

Cureus
2025

Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS).

Biomedicines
2025

Complex Genetics and Regulatory Drivers of Hypermobile Ehlers-Danlos Syndrome: Insights from Genome-Wide Association Study Meta-analysis.

medRxiv : the preprint server for health sciences
2026

Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Study.

LGBT health
2025

Improvement in Upper Limb and Systemic Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Symptoms After Surgical Treatment of Neurogenic Thoracic Outlet Syndrome.

Cureus
2025

Proteomic discoveries in hypermobile Ehlers-Danlos syndrome reveal insights into disease pathophysiology.

ImmunoHorizons
2025

KLK15 alters connective tissues in hypermobile Ehlers-Danlos syndrome.

iScience
2025

Defining the Chronic Complexities of hEDS and HSD: A Global Survey of Diagnostic Challenges, Life-Long Comorbidities, and Unmet Needs.

Journal of clinical medicine
2025

Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSD.

Frontiers in medicine
2025

Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.

American journal of medicine open
2025

A Case of Complex Regional Pain Syndrome With Hypermobile Ehlers-Danlos Syndrome and Mast Cell Activation Syndrome: The Role of Unconventional Therapies.

Cureus
2025

Risk factors of patellofemoral instability in patients with hypermobile Ehlers-Danlos syndrome.

Archives of orthopaedic and trauma surgery
2025

Non-Traumatic Arytenoid Subluxation in a Patient With Hypermobile Ehlers-Danlos Syndrome.

The Laryngoscope
2025

Association Between Orthostatic Intolerance Symptoms and Cognitive Complaints in Hypermobile Ehlers-Danlos Syndrome (hEDS) and Joint Hypermobility Spectrum Disorder (JHSD): A Cross-Sectional Analysis.

Cureus
2025

Abdominal Compression Syndromes in the Hypermobile Ehlers-Danlos Syndrome.

American journal of medical genetics. Part A
2025

Orthopaedic Manifestations in Hypermobile Ehlers-Danlos Syndrome.

The Journal of bone and joint surgery. American volume
2025

Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome.

Pediatric rheumatology online journal
2025

User-Driven Development of a Digital Behavioral Intervention for Chronic Pain: Multimethod Multiphase Study.

JMIR formative research
2025

Walking and running in people who are hypermobile: A scoping review.

Gait &amp; posture
2025

A qualitative investigation of Ehlers-Danlos syndrome genetics triage.

Journal of genetic counseling
2025

Pain and physical function affecting quality of life in patients with osteogenesis imperfecta, X-linked hypophosphatemia, and hypermobile Ehlers-Danlos syndrome.

JBMR plus
2025

Fascial Pathophysiology in Hypermobility Spectrum Disorders and Hypermobile Ehlers-Danlos Syndrome: A Review of Emerging Evidence.

International journal of molecular sciences
2026

Understanding the issues of hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome in primary care: a qualitative integrative review.

Disability and rehabilitation
2025

Pain intensity in anatomical regions in relation to psychological factors in hypermobile Ehlers-Danlos syndrome.

Scandinavian journal of pain
2025

Autonomic and sensory dysfunction in hypermobile Ehlers-Danlos syndrome: How do small fibers contribute?

Autonomic neuroscience : basic &amp; clinical
2025

Neuropsychological Function and the Relationship Between Subjective Cognition, Objective Cognition, and Symptoms in Hypermobile Ehlers-Danlos Syndrome.

Brain and behavior
2025

Hypermobile Ehlers-Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing.

Genes
2025

AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2025

Association of postural orthostatic tachycardia syndrome, hypermobility spectrum disorders, and mast cell activation syndrome in young patients; prevalence, overlap and response to therapy depends on the definition.

Frontiers in neurology
2025

Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehlers-Danlos Syndrome?

Alimentary pharmacology &amp; therapeutics
2025

A qualitative study exploring participants' feelings about an online pilates program designed for people with hypermobility disorders.

Journal of bodywork and movement therapies
2025

Self-reported Demographics of 154 Hypermobile Ehlers-Danlos Syndrome Patients.

American journal of physical medicine &amp; rehabilitation
2025

HOPE for Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD)-A Pilot Randomised Controlled Trial of Feasibility, Acceptability and Appropriateness.

European journal of pain (London, England)
2025

Depressive symptoms are highly prevalent and associated with fatigue and pain catastrophizing in the Hypermobility Spectrum Disorders and hypermobile Ehlers Danlos syndrome: a cross-sectional study.

Rheumatology international
2025

The Complexities of Navigating the Healthcare System as an Autistic Individual with Ehlers-Danlos Syndrome: A Patient Perspective.

Journal of patient experience
2025

The Contradictions in the Criteria for Diagnosing Hypermobile Ehlers-Danlos Syndrome as Reflecting Some of the Philosophical Debates about the Threshold between the Normal and the Pathological.

The Journal of medicine and philosophy
2025

Insomnia due to a dislocation storm in hypermobile Ehlers-Danlos syndrome with small fibre neuropathy and recurrent syncope.

European journal of translational myology
2025

Symptomatic joint hypermobility is not a barrier to attendance, graduation, or satisfaction for adults participating in a multidisciplinary pain rehabilitation program.

Frontiers in pain research (Lausanne, Switzerland)
2025

Sexual dysfunction in women with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: an online community-based study.

Rheumatology advances in practice
2025

How Do Patients with Hypermobile Ehlers-Danlos Syndrome Cope with This Medical Condition? An Analysis of Autobiographical Narratives in Relation to Pain Perception and Affect Regulation Capabilities.

Healthcare (Basel, Switzerland)
2025

Prevalence of psychiatric and sleep disorders and their impact on quality of life in children with hypermobile Ehlers-Danlos syndrome: an observational study.

Rheumatology international
2025

UK Medical Cannabis Registry: An Analysis of Outcomes of Medical Cannabis Therapy for Hypermobility-Associated Chronic Pain.

ACR open rheumatology
2025

Hypothesis: Young infant bone strength is a multifactorial trait.

Medicine
2025

Radiographic Identification of Visceroptosis in Patients With Hypermobile Ehlers-Danlos Syndrome With Functional Gastrointestinal Symptoms Compared With Healthy Subjects.

Clinical and translational gastroenterology
2025

The Relationship Between Fatigue, Pain Interference, Pain-Related Distress, and Avoidance in Pediatric Hypermobile Ehlers-Danlos Syndrome.

Children (Basel, Switzerland)
2025

Suspected Mitochondrial Dysfunction and Complex Pathophysiology in Fatal Hypermobile Ehlers-Danlos Syndrome: Insights from a Case Report and Post-Mortem Findings.

Biomedicines
2025

Mitochondrial Dysfunction and Its Potential Molecular Interplay in Hypermobile Ehlers-Danlos Syndrome: A Scoping Review Bridging Cellular Energetics and Genetic Pathways.

Current issues in molecular biology
2025

An evaluation of practices and policies used in genetics clinics across the United States to manage referrals for Ehlers-Danlos and hypermobility syndromes.

Genetics in medicine open
2025

Head Posture and Upper Spine Morphological Deviations in Patients With Hypermobile Ehlers-Danlos Syndrome.

Orthodontics &amp; craniofacial research
2025

A case of massive hematoma: reflections on hypermobile Ehlers-Danlos syndrome.

Frontiers in medicine
2025

Navigating HOPE (Hypermobile Online Pain managemEnt): Perspectives and Experiences From People With Hypermobile Ehlers-Danlos Syndrome or Hypermobility Spectrum Disorder on a Condition-Specific Online Pain Management Programme.

Health expectations : an international journal of public participation in health care and health policy
2025

Profiling hypermobile Ehlers-Danlos syndrome (hEDS): factors in health and wellbeing with chronic conditions and opportunities for improving self-management.

Disability and rehabilitation
2024

The Spider; A Multisystemic Symptom Impact Tool for People with Hypermobility-Related Disorders. Initial Validation in Adolescents.

Journal of pediatrics. Clinical practice
2025

Bone Densitometry Parameters in Females with Ehlers-Danlos Syndrome-Does the Hypermobile Subtype Increase the Risk of Low Bone Mass in Patients with Ehlers-Danlos Syndrome?

Journal of clinical medicine
2024

Comorbidities and neurosurgical interventions in a cohort with connective tissue disorders.

Frontiers in neurology
2025

Management of Maternal Genetic Conditions in Pregnancy, Part 1: Disorders of the Connective Tissue, Muscle, Vascular, and Skeletal Systems.

Obstetrical &amp; gynecological survey
2024

Tracking changes in autonomic function by coupled analysis of wavelet-based dispersion of heart rate variability and gastrointestinal symptom severity in individuals with hypermobile Ehlers-Danlos syndrome.

Frontiers in neurology
2025

The prevalence of hypermobile Ehlers-Danlos syndrome at a gender-affirming primary care clinic.

SAGE open medicine
2025

Hypermobile type Ehlers-Danlos syndrome and generalized hypermobile spectrum disorder treatment preferences - a cross-sectional survey of patients.

Rheumatology international
2025

Hypermobility Syndromes and Their Impact on Gastrointestinal Illnesses: A Review for Gastroenterologists.

The American journal of gastroenterology
2024

The First Patient with Tinea Manuum because of Trichophyton erinacei Isolated in Malta.

Skinmed
2025

Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers-Danlos Syndrome.

Alimentary pharmacology &amp; therapeutics
2024

Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

Rheumatology advances in practice
2025

Shprintzen - Goldberg syndrome without intellectual disability: A clinical report and review of literature.

European journal of medical genetics
2024

Presentation and physical therapy management using a neuroplasticity approach for patients with hypermobility-related upper cervical instability: a brief report.

Frontiers in neurology
2024

Recurrent adnexal torsion in a teenager with hypermobile Ehlers-Danlos syndrome: A case report.

Case reports in women's health
2024

Hypermobile Ehlers Danlos for the Primary Care Provider.

Missouri medicine
2025

A machine learning approach to stratify patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders according to disorders of gut brain interaction, comorbidities and quality of life.

Neurogastroenterology and motility
2024

Hippotherapy in the management of hypermobile Ehlers-Danlos syndrome.

BMJ case reports
2024

Overlapping conditions in Long COVID at a multisite academic center.

Frontiers in neurology
2025

Exploring signs of central sensitization in adolescents with hypermobility Spectrum disorder or hypermobile Ehlers-Danlos syndrome.

European journal of pain (London, England)
2025

Prevalence of Autoantibodies in Patients with Hereditary Alpha-Tryptasemia.

International archives of allergy and immunology
2024

Hypoglycemia Associated With Hypermobile Ehlers-Danlos Syndrome.

JCEM case reports
2024

Cesarean Delivery in a Patient With Hypermobile Ehlers-Danlos Syndrome: A Case Report.

Cureus
2024

The prevalence of multisystem diagnoses among young patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: A retrospective analysis using a large healthcare claims database.

Medicine
2024

Decoding the Genetic Basis of Mast Cell Hypersensitivity and Infection Risk in Hypermobile Ehlers-Danlos Syndrome.

Current issues in molecular biology
2024

Cardiovascular, autonomic symptoms and quality of life in children with hypermobile Ehlers-Danlos syndrome.

SAGE open medicine
2024

Defining a core outcome set for hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome: A Delphi consensus study.

Clinical rheumatology
2024

The Effectiveness of Conservative Interventions on Pain, Function, and Quality of Life in Adults with Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorders and Shoulder Symptoms: A Systematic Review.

Archives of rehabilitation research and clinical translation
2024

Oral health-related quality of life among women with temporomandibular disorders and hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder.

Journal of the American Dental Association (1939)
2024

Assessing the Utility of a Patient-Facing Diagnostic Tool Among Individuals With Hypermobile Ehlers-Danlos Syndrome: Focus Group Study.

JMIR formative research
2024

Low vitamin C status and hypermobility-related disorders in patients with bleeding disorder of unknown cause.

Haemophilia : the official journal of the World Federation of Hemophilia
2024

Long COVID and hypermobility spectrum disorders have shared pathophysiology.

Frontiers in neurology
2025

Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker.

American journal of medical genetics. Part A
2024

Pediatric Outcomes After Robotic Median Arcuate Ligament Release, Celiac Ganglionectomy, and Lymphadenectomy.

Journal of pediatric surgery
2025

Evidence for central sensitization as classified by the central sensitization inventory in patients with pain and hypermobility.

Pain practice : the official journal of World Institute of Pain
2024

Longitudinal echocardiography in pediatric patients with hypermobile Ehlers-Danlos syndrome.

American journal of medical genetics. Part A
2024

Co-occurrence of tethered cord syndrome and cervical spine instability in hypermobile Ehlers-Danlos syndrome.

Frontiers in neurology
2024

Hypermobile Ehlers-Danlos syndrome and spontaneous CSF leaks: the connective tissue conundrum.

Frontiers in neurology
2024

The Spider: a visual, multisystemic symptom impact questionnaire for people with hypermobility-related disorders-validation in adults.

Clinical rheumatology
2024

Dextrose Prolotherapy for the Treatment of Chronic Shoulder Pain in Patients With Joint Hypermobility: A Case Series.

Clinical medicine insights. Arthritis and musculoskeletal disorders
2024

Multisystem Involvement in a Pediatric Patient With Hypermobile Ehlers-Danlos Syndrome: A Case Report of the Diagnostic Complexity and Management Challenges.

Cureus
2024

Chronic Pain and Joint Hypermobility: A Brief Diagnostic Review for Clinicians and the Potential Application of Infrared Thermography in Screening Hypermobile Inflamed Joints.

The Yale journal of biology and medicine
2024

Variants in the Kallikrein Gene Family and Hypermobile Ehlers-Danlos Syndrome.

Research square
2024

Esophageal Striae as a Possible Gastrointestinal Manifestation of Hypermobile Ehlers-Danlos Syndrome.

ACG case reports journal
2024

Social media use by patients with hypermobile Ehlers-Danlos syndrome.

Molecular genetics &amp; genomic medicine
2024

Evaluating the effects of two different kinesiology taping techniques on shoulder range of motion and proprioception in patients with hypermobile Ehlers-Danlos syndrome: a randomized controlled trial.

Frontiers in rehabilitation sciences
2025

Psychometric properties of the Mini-Balance Evaluation Systems Test and physical function measures in patients with Ehlers-Danlos syndrome/hypermobility spectrum disorders.

Disability and rehabilitation
2024

Phenotypic Clusters and Multimorbidity in Hypermobile Ehlers-Danlos Syndrome.

Mayo Clinic proceedings. Innovations, quality &amp; outcomes
2024

Airway Complications in a Patient With Ehlers-Danlos Syndrome: A Case Report.

AANA journal
2024

Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.

PloS one
2024

High prevalence of gastrointestinal disorders in a large cohort of patients with joint hypermobility.

Journal of pediatric gastroenterology and nutrition
2025

An online pain management program for people with hypermobile Ehlers-Danlos Syndrome or hypermobility spectrum disorder: a three-staged development process.

Disability and rehabilitation
2024

Risk factors associated with symptoms of temporomandibular disorders among women with hypermobile Ehlers-Danlos syndrome: Questionnaire-based study in Finland and Sweden.

Journal of oral rehabilitation
2024

Impairment of lung volume perception and breathing control in hypermobile Ehlers-Danlos syndrome.

Scientific reports
2024

Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study.

Frontiers in cardiovascular medicine
2024

Patient experiences of receiving a diagnosis of hypermobile Ehlers-Danlos syndrome.

American journal of medical genetics. Part A
2024

Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data.

Frontiers in neurology
2024

Generalized Joint Hypermobility: A Statistical Analysis Identifies Non-Axial Involvement in Most Cases.

Children (Basel, Switzerland)
2024

Effective Doses of Low-Dose Naltrexone for Chronic Pain - An Observational Study.

Journal of pain research
2024

Prevalence of MTHFR Polymorphisms in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobile Spectrum Disorders in a US Hypermobility Clinic.

ACR open rheumatology
2024

Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccination.

PloS one
2024

Beyond Confirmed Mast Cell Activation Syndrome: Approaching Patients With Dysautonomia and Related Conditions.

The journal of allergy and clinical immunology. In practice
2024

A Possible Newly Defined and Treatable Secondary Cause of Early Morning Wake-Up Headaches in an Older Hypermobile Woman: Nutcracker Physiology with Spinal Epidural Venous Congestion.

Case reports in neurology
2024

Assessment of gait mechanics and muscle strength in hypermobile Ehlers Danlos Syndrome.

Clinical biomechanics (Bristol, Avon)
2024

Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.

Brain and behavior
2024

Mast cell activation and nutritional disorders in patients with hypermobility.

Current opinion in gastroenterology
2024

The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.

Gait &amp; posture
2024

Mismatch between subjective and objective dysautonomia.

Scientific reports
2024

Cardiovascular Symptoms, Dysautonomia, and Quality of Life in Adult and Pediatric Patients with Hypermobile Ehlers-Danlos Syndrome: A Brief Review.

Current cardiology reviews
2024

Twenty-Three-Year-Old Patient With Chronic Pain and Fainting Spells-A Clinical Vignette.

American journal of physical medicine &amp; rehabilitation
2024

Systemic pain relief after omalizumab injection in patient with hypermobile Ehlers-Danlos syndrome: A case report.

Clinical case reports
2024

Postural orthostatic tachycardia syndrome after COVID-19 vaccination.

Heart rhythm
2024

Long COVID and the diagnosis of underlying hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

PM &amp; R : the journal of injury, function, and rehabilitation
2024

Physician- and patient-reported dermatologic comorbidities of hypermobile Ehlers-Danlos syndrome.

Journal of the American Academy of Dermatology
2023

Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series.

Journal of personalized medicine
2023

Asymptomatic Infant Rib Fractures Are Primarily Non-abuse-Related and Should Not Be Used to Assess Physical Child Abuse.

Children (Basel, Switzerland)
2024

Effects of hypermobile Ehlers-Danlos syndrome patients on the workflow and professional satisfaction of genetic counselors.

Journal of genetic counseling
2024

Effects of multidisciplinary rehabilitation in a patient with Ehlers-Danlos and Behçet's syndromes: a paradigmatic case report according to the narrative medicine.

Disability and rehabilitation
2024

Microvascular status and skin thickness in adults with hypermobile Ehlers-Danlos syndrome: a pilot investigation.

Clinical and experimental rheumatology
2024

Breast surgery in patients with hypermobile Ehlers-Danlos syndrome.

Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS
2024

Comprehensive Assessment of Nutrition and Dietary Influences in Hypermobile Ehlers-Danlos Syndrome-A Cross-Sectional Study.

The American journal of gastroenterology
2023

Childbearing with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Large International Survey of Outcomes and Complications.

International journal of environmental research and public health
2023

Co-Created Solutions for Perinatal Professionals and Childbearing Needs for People with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

International journal of environmental research and public health
2023

A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice.

Pediatric rheumatology online journal
2024

Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

Disability and rehabilitation
2024

Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome.

Journal of medical genetics
2024

Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.

American journal of medical genetics. Part A
2023

Exploring Comorbidities in Adolescent and Young Adults with Hypermobile Ehlers-Danlos Syndrome with and without a Surgical History: A Preliminary Investigation.

Children (Basel, Switzerland)
2023

Complex Presentations, Identification and Treatment of Mast Cell Activation Syndrome and Associated Conditions: A Case Report.

Integrative medicine (Encinitas, Calif.)
2023

Prevalence and quality of temporomandibular disorders, chronic pain and psychological distress in patients with classical and hypermobile Ehlers-Danlos syndrome: an exploratory study.

Orphanet journal of rare diseases
2023

Narrative Review of Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies.

US cardiology
2023

Mast Cell Involvement in the Pathogenesis of Selected Musculoskeletal Diseases.

Life (Basel, Switzerland)
2024

Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.

The Laryngoscope
2023

The Language of Pain in the Hypermobile Ehlers-Danlos Syndrome: Metaphors as a Key to Understanding the Experience of Pain and as a Rehabilitation Tool.

Brain sciences
2023

Clinician-associated traumatization from difficult medical encounters: Results from a qualitative interview study on the Ehlers-Danlos Syndromes.

SSM. Qualitative research in health
2023

Overall comorbidities in functional neurological disorder: A narrative review.

L'Encephale
2023

Multiple Sustainable Benefits of a Rehabilitation Program in Therapeutic Management of Hypermobile Ehlers-Danlos Syndrome: A Prospective and Controlled Study at Short- and Medium-Term.

Archives of physical medicine and rehabilitation
2023

A novel method of assessing balance and postural sway in patients with hypermobile Ehlers-Danlos syndrome.

Frontiers in medicine
2023

Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.

Rheumatology international
2023

Central sensitization in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome-a feasibility study.

Pilot and feasibility studies
2023

Clinical trajectory of hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders in older adults.

Journal of the American Association of Nurse Practitioners
2023

Validation of the neuroconnective endophenotype questionnaire (NEQ): a new clinical tool for medicine and psychiatry resulting from the contribution of Ehlers-Danlos syndrome.

Frontiers in medicine
2024

Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.

Disability and rehabilitation
2023

Assessment of functional respiratory complaints and related factors in people with hypermobile Ehlers-Danlos syndrome: Cross-sectional study.

Respiratory medicine and research
2024

Effects of compression garments on balance in hypermobile Ehlers-Danlos syndrome: a randomized controlled trial.

Disability and rehabilitation
2023

Somatic symptoms, pain, catastrophizing and the association with disability among children with heritable connective tissue disorders.

American journal of medical genetics. Part A
2023

High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities.

Frontiers in medicine
2023

Pediatric joint hypermobility: a diagnostic framework and narrative review.

Orphanet journal of rare diseases
2023

Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome.

Genetics in medicine open
2024

Patients' strategies for numeric pain assessment: a qualitative interview study of individuals with hypermobile Ehlers-Danlos Syndrome.

Disability and rehabilitation
2023

Low prevalence of positive hydrogen breath tests in patients with functional gastrointestinal conditions and hypermobile Ehlers-Danlos syndrome.

Neurogastroenterology and motility
2023

Habituation deficit of visual evoked potentials in migraine patients with hypermobile Ehlers-Danlos syndrome.

Frontiers in neurology
2023

Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial.

JMIR research protocols
Ver todos os 251 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Ehlers-Danlos hipermobilidade.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Ehlers-Danlos hipermobilidade

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Children and adolescents with disorders of gut-brain interaction with comorbid hypermobility and orthostatic intolerance have worse outcomes.
    Journal of pediatric gastroenterology and nutrition· 2026· PMID 41858089mais citado
  2. Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.
    Neurology international· 2026· PMID 41745718mais citado
  3. Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.
    PloS one· 2026· PMID 41576003mais citado
  4. Sleep-Related Hypoventilation in a Patient With Ehlers-Danlos Syndrome.
    Cureus· 2026· PMID 41873264mais citado
  5. A laboratory micro-CT technique is useful to visualize and characterize dermal skin components in a 3D manner.
    Experimental and therapeutic medicine· 2026· PMID 41858767mais citado
  6. Females with hypermobile Ehlers-Danlos syndrome self-report more sexual problems than chronic pain controls without hypermobility, males, or patients with hypermobile spectrum disorders.
    Front Reprod Health· 2026· PMID 41993759recente
  7. Tourniquet Use and Anesthesiology Considerations in Patients With Hypermobile Ehlers-Danlos Syndrome: Balancing Orthopedic Needs With Anesthetic Safety.
    Cureus· 2026· PMID 41978595recente
  8. 2-Chloroprocaine vs. Lidocaine in a Patient With Hypermobile Ehlers-Danlos Syndrome and a History of Local Anesthetic Resistance: A Case Report.
    Case Rep Anesthesiol· 2026· PMID 41970145recente
  9. Multimodal Wearable and Survey Data Reveal Distinct Physiologic Profiles in Hypermobile-Ehlers Danlos Syndrome for Screening Advancements.
    medRxiv· 2026· PMID 41959756recente
  10. The lived experience of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders in the United Kingdom: findings from a national cross-sectional survey.
    Disabil Rehabil· 2026· PMID 41928730recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:285(Orphanet)
  2. OMIM OMIM:130020(OMIM)
  3. MONDO:0007523(MONDO)
  4. GARD:2081(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q3508607(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Ehlers-Danlos hipermobilidade
Compêndio · Raras BR

Síndrome Ehlers-Danlos hipermobilidade

ORPHA:285 · MONDO:0007523
Prevalência
1-5 / 10 000
Herança
Autosomal dominant, Autosomal recessive
CID-10
Q79.6 · Síndrome de Ehlers-Danlos
CID-11
Ensaios
6 ativos
Início
All ages
Prevalência
12.5 (Europe)
MedGen
UMLS
C0268337
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades